Recruiting NA Benign Prostatic Hyperplasia

Compares treatment options for Benign Prostatic Hyperplasia

Official title Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP

ClinicalTrials.gov ID: NCT05678452

What this study is testing

What it's testing
Holmium laser enucleation (HOLEP) has became a standard of treatment of large prostates that indicates surgery. HOLEP is widely used nowadays.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 45 and older, men only

You may be able to join if

  • large prostate indicated for surgical intervention.

You likely can't join if

  • prostate cancer
  • recurrent adenomas
  • associated neurologic factors that may affect outcomes (e.g., neurogenic bladder)

The study team makes the final eligibility decision.

Where it's taking place

  • Cairo, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling male, 45 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.